Patents by Inventor Steven Suddarth

Steven Suddarth has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220397621
    Abstract: Spin resonance spectroscopy and/or imaging is achieved using a system that combines longitudinal (e.g., along the z-axis) detection with a modulated fictitious field generated by a transverse plane (e.g., xy-plane) RF field. Based on z-axis detection of magnetization polarized by this fictitious field as it is modulated (e.g., modulated on and off, or otherwise), spin resonance signals (e.g., EPR, NMR) are measurable with high isolation simultaneous transmit and receive capability. Additionally or alternatively, spin relaxation times can be measured using the described systems.
    Type: Application
    Filed: March 8, 2022
    Publication date: December 15, 2022
    Inventors: Xueyan Tang, Michael Garwood, Steven Suddarth
  • Patent number: 7501828
    Abstract: A switchable birdcage coil functioning as a transmitter coil and a separate RF surface coil functioning as the receiver coil are utilize in NMR and MRI apparatus. To prevent the switchable birdcage coil from absorbing energy by coupling to the receiver coil or by absorbing power from the RF field produced by the precessing nuclear spins, one or more of the reactive elements of the birdcage coil are switched from a normal reactive impedance state to a high impedance state. The high impedance state is formed by switchably combining the reactive element with a complementary reactive element thereby forming parallel resonant high impedance circuit that is tuned to resonate at the NMR frequency.
    Type: Grant
    Filed: December 19, 2007
    Date of Patent: March 10, 2009
    Assignee: Varian, Inc.
    Inventors: Wai Ha Wong, Alan R. Rath, Steven A. Suddarth
  • Patent number: 7011814
    Abstract: Methods, systems, devices and computer program products monitor in vivo detected radiation in a target localized site within a subject, over a selected time period, to do one or more of: (a) quantify a radiation dose received at a local site; (b) assess bioreceptiveness to a particular treatment time or type; (c) evaluate the pharmacokinetics of a radiolabeled analyte corresponding to a non-radiolabeled analyte; (d) monitor or evaluate metabolic activity; or (e) evaluate a tumor prior to or after a therapeutic treatment.
    Type: Grant
    Filed: April 22, 2002
    Date of Patent: March 14, 2006
    Assignee: Sicel Technologies, Inc.
    Inventors: Steven Suddarth, Charles W. Scarantino, Robert D. Black
  • Publication number: 20050287065
    Abstract: System for analyzing an in vivo response of a subject include a radiation detector for detecting radiation present in at least one localized solid tissue region of interest in a subject associated with internal activity of an administered quantity of an analyte comprising at least one of C-14 labeled glucose, a C-14 labeled constituent thereof, and a C-14 labeled glucose derivative, in the at least one solid tissue region of interest over a desired time interval of interest; and a reader in communication with the implantable detector for collecting radiation data from the detector associated with the detected radiation to determine at least one of the following; the in vivo dynamic, kinetic, and metabolic response of the subject.
    Type: Application
    Filed: August 22, 2005
    Publication date: December 29, 2005
    Inventors: Steven Suddarth, Charles Scarantino, Robert Black
  • Publication number: 20030012731
    Abstract: Methods, systems, devices and computer program products monitor in vivo detected radiation in a target localized site within a subject, over a selected time period, to do one or more of: (a) quantify a radiation dose received at a local site; (b) assess bioreceptiveness to a particular treatment time or type; (c) evaluate the pharmacokinetics of a radiolabeled analyte corresponding to a non-radiolabeled analyte; (d) monitor or evaluate metabolic activity; or (e) evaluate a tumor prior to or after a therapeutic treatment.
    Type: Application
    Filed: April 22, 2002
    Publication date: January 16, 2003
    Inventors: Steven Suddarth, Charles W. Scarantino, Robert D. Black